Daniel S. Jonas - Mar 1, 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Special Counsel & Corp Secy
Signature
Daniel S. Jonas
Stock symbol
CNMD
Transactions as of
Mar 1, 2023
Transactions value $
-$353,294
Form type
4
Date filed
3/3/2023, 03:45 PM
Previous filing
Jun 5, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +2.5K +20.35% $0.00 14.8K Mar 1, 2023 Direct
transaction CNMD Common Stock Tax liability -$70.8K -736 -4.98% $96.16 14K Mar 1, 2023 Direct
transaction CNMD Common Stock Options Exercise $324K +5.4K +38.44% $59.96 19.4K Mar 2, 2023 Direct
transaction CNMD Common Stock Sale -$520K -5.4K -27.77% $96.25 14K Mar 2, 2023 Direct
transaction CNMD Common Stock Options Exercise $394K +5K +35.59% $78.76 19K Mar 2, 2023 Direct
transaction CNMD Common Stock Sale -$480K -5K -26.25% $96.08 14K Mar 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -2.5K -100% $0.00* 0 Mar 1, 2023 Common Stock 2.5K $0.00 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +3K $0.00 3K Mar 1, 2023 Common Stock 3K $0.00 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5.4K -100% $0.00* 0 Mar 2, 2023 Common Stock 5.4K $59.96 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5K -50% $0.00 5K Mar 2, 2023 Common Stock 5K $78.76 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period